[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Infection Control Market by Product (Sterilization (Hydrogen Peroxide, EtO, Gamma, E-Beam), Disinfection (Wipes, Liquids, Disinfectors), Services, Gowns, Endoscope Reprocessing), End User (Hospital & Clinics, Pharmaceuticals) - Global Forecast to 2029

February 2024 | 616 pages | ID: SF5416D790FEN
MarketsandMarkets

US$ 3,217.50 US$ 4,950.00 -35 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The infection control market is valued at an estimated USD 51.0 billion in 2024 and is projected to reach USD 69.2 billion by 2029, at a CAGR of 6.3% during the forecast period. Recent key trends driving the infection control market include increased focus on antimicrobial surfaces, adoption of UV-C disinfection technology, and growth in demand for point-of-care testing. These trends are driven by heightened awareness of infection prevention, regulatory mandates, and the need for efficient and effective healthcare practices.

Opportunities in the infection control market include increasing adoption of advanced technologies, rising demand for infection prevention in emerging economies, and growing awareness of healthcare-associated infections. These opportunities can drive market growth by innovation, expanding market reach, and fostering greater investment in infection control solutions worldwide.

“The endoscope reprocessing products segment is projected to witness the highest growth in the infection control market, by products, during the forecast period.”

The infection control market can be broadly classified into sterilization products & services, consumables & accessories, cleaning & disinfection products, protective barriers, and endoscope reprocessing products depending on the product. The endoscope reprocessing products segment is projected to witness the highest growth in the infection control market, by products, during the forecast period. The endoscope reprocessing products market is growing, commanding significant attention and dominance. This segment specializes in providing essential sterilization and disinfection solutions tailored specifically for endoscopic devices used in medical procedures. Its dominance is attributed to the increasing utilization of endoscopic procedures worldwide, coupled with stringent regulatory requirements mandating effective reprocessing to prevent Healthcare-Associated Infection. Consequently, the segment continues to experience robust growth due to its critical role in maintaining patient safety and infection prevention standards.

“Hospitals and clinics segment, by end-user, has the highest market share.”

Hospitals and clinics represent the largest end user segment in the infection control market, commanding a significant share due to several key factors. As primary providers of healthcare services, hospitals and clinics prioritize infection control to ensure patient safety and maintain high standards of care. The prevalence of Healthcare-Associated Infections (HAIs) within these settings drives the demand for infection control products and services.

Additionally, the increasing number of hospitals and clinics globally, coupled with the rising volume of surgical procedures performed, further fuels market growth within this segment. Moreover, the growing geriatric population, which is more susceptible to chronic diseases and infections, contributes to the demand for infection control measures in healthcare facilities. Government initiatives aimed at improving infection prevention standards and regulations also drive market growth within hospitals and clinics, reinforcing their position as the primary end user segment in the infection control market.

“Asia Pacific market to witness the highest growth during the forecast period.”

In the year 2022, the Asia Pacific region accounted for the highest growth rate in the infection control market, with countries like India and China standing out as areas with the highest growth potential. The major factors promoting the growth of the infection control market in this region are region's expanding healthcare infrastructure, increasing adoption of advanced infection control technologies, and supportive government initiatives aimed at enhancing infection prevention measures.

A breakdown of the primary participants (supply-side) for the infection control market referred to for this report is provided below:
  • By Company Type: Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
  • By Designation: C-level: 28%, Director-level: 43%, and Others: 39%
  • By Region: North America: 35%, Europe: 20%, Asia Pacific: 30%, Latin America: 7%; Middle East & Africa: 5%, and GCC Countries: 3%
The prominent players operating in the infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Advanced Sterilization Products (US), Sotera Health LLC (US), MMM Group (Germany), MATACHANA GROUP (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), Olympus Corporation (Japan). Melag Medizintechnik GmbH & Co. KG (Germany), Miele Group (Germany), Systec GmbH & Co. KG(Germany), Contec, Inc. (US), Continental Equipment Company (US), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US),

Research Coverage:

The market study covers the infection control market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product & service, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall infection control market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
  • Analysis of key drivers (Rising prevalence of healthcare-associated infections (HAIs), Growing number of surgeries, Advancement in reprocessing technologies, Rising emphasis on the sterilization and disinfection of food, Advancements in sterilization equipment technology, Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (Growing concerns about the safety of reprocessed instruments, Consequences associated with the use of chemical disinfectants, High cost associated with endoscopy reprocessing coupled with the limited reimbursements in developing nations, ), opportunities (The increasing prevalence of medical devices and pharmaceutical companies in developing nations, Growing utilization of E-beam sterilization, Reintegration of ethylene oxide sterilization) and challenges (Sterilization of Advanced Medical Devices, Alternative methods for surface disinfection, Increasing adoption of single-use medical nonwovens and devices).
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection control market. The report analyzes this market by product & service, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection control market.
  • Market Development: Comprehensive information on the lucrative emerging markets by product & service, end user, and region.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global infection control market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global infection control market.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 PRODUCT DEFINITION
  1.2.2 END USER DEFINITION
  1.2.3 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED
  1.3.3 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 STERILIZATION MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION (STERIS PLC)
FIGURE 7 ENDOSCOPE REPROCESSING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION (ASP)
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
FIGURE 10 MARKET SIZE ESTIMATION: STERILIZATION EQUIPMENT
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029): IMPACT LEVEL OF CAGR
FIGURE 12 CAGR PROJECTIONS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
  2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

FIGURE 14 CLEANING & DISINFECTION PRODUCTS TO BE LARGEST SEGMENT DURING FORECAST PERIOD
FIGURE 15 STERILIZATION EQUIPMENT SEGMENT TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 16 DISINFECTANTS TO BE LEADING SEGMENT DURING FORECAST PERIOD
FIGURE 17 ENDOSCOPE REPROCESSING CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023
FIGURE 18 MEDICAL NONWOVENS TO BE LEADING SEGMENT DURING FORECAST PERIOD
FIGURE 19 HOSPITALS & CLINICS TO DOMINATE INFECTION CONTROL MARKET DURING FORECAST PERIOD
FIGURE 20 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR INFECTION CONTROL

4 PREMIUM INSIGHTS

4.1 SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN INFECTION CONTROL MARKET
FIGURE 21 HIGH INCIDENCE OF HAIS AND GROWING FOCUS ON FOOD STERILIZATION AND DISINFECTION TO DRIVE MARKET
4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY
FIGURE 22 JAPAN LED INFECTION CONTROL MARKET IN ASIA PACIFIC IN 2023
4.3 INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 CHINA TO REGISTER HIGHEST REVENUE GROWTH DURING FORECAST PERIOD
4.4 INFECTION CONTROL MARKET, BY REGION (2021–2029)
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE INFECTION CONTROL MARKET DURING FORECAST PERIOD
4.5 INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN INFECTION CONTROL MARKET
  5.2.1 MARKET DRIVERS
    5.2.1.1 Rising prevalence of healthcare-associated infections (HAIs)
    5.2.1.2 Growing number of surgeries
    5.2.1.3 Advancement in reprocessing technologies
    5.2.1.4 Rising emphasis on sterilization and disinfection of food
    5.2.1.5 Advancements in sterilization equipment technology
    5.2.1.6 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals
  5.2.2 MARKET RESTRAINTS
    5.2.2.1 Growing concerns about safety of reprocessed instruments
    5.2.2.2 Consequences associated with use of chemical disinfectants
    5.2.2.3 High cost associated with endoscopy reprocessing coupled with limited reimbursements in developing nations
  5.2.3 MARKET OPPORTUNITIES
    5.2.3.1 Increasing prevalence of medical devices and pharmaceutical companies in developing nations
    5.2.3.2 Growing utilization of E-beam sterilization
    5.2.3.3 Reintegration of ethylene oxide sterilization
  5.2.4 MARKET CHALLENGES
    5.2.4.1 Sterilization of advanced medical devices
    5.2.4.2 Alternative methods for surface disinfection
    5.2.4.3 Increasing adoption of single-use medical nonwovens and devices
5.3 INDUSTRY TRENDS
  5.3.1 ARTIFICIAL INTELLIGENCE (AI) INTEGRATION WITH INFECTION CONTROL
  5.3.2 POINT-OF-CARE TESTING IN INFECTION CONTROL
5.4 VALUE CHAIN ANALYSIS
FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
  5.5.1 SUPERCRITICAL CO2 TECHNOLOGY
  5.5.2 ULTRA-HIGH-PRESSURE STERILIZATION
  5.5.3 NITROGEN DIOXIDE (NO2)
  5.5.4 PULSED ELECTRIC FIELD (PEF) STERILIZATION
  5.5.5 PLASMA STERILIZATION
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.6.1 THREAT OF NEW ENTRANTS
  5.6.2 THREAT OF SUBSTITUTES
  5.6.3 BARGAINING POWER OF SUPPLIERS
  5.6.4 BARGAINING POWER OF BUYERS
  5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
  5.7.1 REGULATORY ANALYSIS
    5.7.1.1 North America
      5.7.1.1.1 US
FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
      5.7.1.1.2 Canada
TABLE 3 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING
    5.7.1.2 Europe
TABLE 4 STERILIZATION STANDARDS IN EUROPEAN UNION
    5.7.1.3 Asia Pacific
      5.7.1.3.1 Japan
TABLE 5 GUIDELINES FOR INDICATORS
TABLE 6 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES
      5.7.1.3.2 China
      5.7.1.3.3 Australia
    5.7.1.4 Latin America
      5.7.1.4.1 Brazil
      5.7.1.4.2 Mexico
    5.7.1.5 Middle East
    5.7.1.6 Africa
  5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
  5.8.1 PATENT PUBLICATION TRENDS FOR INFECTION CONTROL
FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2014–FEBRUARY 2024)
  5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION CONTROL PATENTS, JANUARY 2014–FEBRUARY 2024
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION CONTROL PATENTS, JANUARY 2014–FEBRUARY 2024
TABLE 12 LIST OF PATENTS IN INFECTION CONTROL MARKET, 2021–2024
5.9 TRADE ANALYSIS
TABLE 13 TOP EXPORTERS OF STERILIZERS FOR MEDICAL, SURGICAL, AND LABORATORY USE
5.10 KEY CONFERENCES & EVENTS
TABLE 14 INFECTION CONTROL MARKET: KEY CONFERENCES & EVENTS (2024)
5.11 ECOSYSTEM/MARKET MAP
FIGURE 32 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS (%)
  5.12.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS
TABLE 16 KEY BUYING CRITERIA FOR TOP THREE PRODUCTS
5.13 UNMET NEEDS: INFECTION CONTROL MARKET
5.14 ADJACENT MARKET ANALYSIS
FIGURE 35 ADJACENT MARKETS OF INFECTION CONTROL MARKET
5.15 SUPPLY CHAIN ANALYSIS
FIGURE 36 SUPPLY CHAIN ANALYSIS: INFECTION CONTROL MARKET
5.16 PRICING ANALYSIS
  5.16.1 AVERAGE SELLING PRICE OF STERILIZERS (PRODUCT USED FOR INFECTION CONTROL), BY TYPE
TABLE 17 AVERAGE SELLING PRICE OF STERILIZERS, BY TYPE, 2022
  5.16.2 AVERAGE SELLING PRICE OF DRY HEAT STERILIZERS (PRODUCT USED FOR INFECTION CONTROL), BY REGION
TABLE 18 AVERAGE SELLING PRICE OF DRY HEAT STERILIZERS, BY REGION, 2023
5.17 AI IN INFECTION CONTROL TOOLS LIKE STERILIZATION EQUIPMENT
5.18 REIMBURSEMENT ANALYSIS
5.19 INVESTMENT AND FUNDING SCENARIO: INFECTION CONTROL MARKET
FIGURE 37 FUNDING AND INVESTMENTS IN INFECTION CONTROL MARKET INCREASED IN 2021

6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE

6.1 INTRODUCTION
TABLE 19 COMMONLY USED INFECTION CONTROL CHEMICALS
TABLE 20 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION)
6.2 STERILIZATION PRODUCTS & SERVICES
TABLE 21 KEY PLAYERS PROVIDING STERILIZATION PRODUCTS AND SERVICES
TABLE 22 STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 23 STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.2.1 STERILIZATION EQUIPMENT
TABLE 24 KEY PLAYERS PROVIDING STERILIZATION EQUIPMENT
TABLE 25 STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 26 STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.1.1 Heat sterilization equipment
TABLE 27 KEY PLAYERS PROVIDING HEAT STERILIZATION EQUIPMENT
TABLE 28 HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 29 HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.1.1 Moist heat sterilizers
        6.2.1.1.1.1 Versatility of moist heat sterilizers to drive market
TABLE 30 MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 31 MOIST HEAT STERILIZERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.1.2 Dry heat sterilizers
        6.2.1.1.2.1 Rising demand for heat-sensitive instruments to drive growth
TABLE 32 DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 33 DRY HEAT STERILIZERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.1.2 Low-temperature sterilization
TABLE 34 LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 35 LOW-TEMPERATURE STERILIZATION MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 36 LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.2.1 Hydrogen peroxide sterilization
        6.2.1.2.1.1 Broad spectrum activity of hydrogen peroxide sterilization to fuel market growth
TABLE 37 HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 38 HYDROGEN PEROXIDE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.2.2 Ethylene oxide (EtO) sterilization
        6.2.1.2.2.1 High penetration capability of EtO sterilization to propel market growth
TABLE 39 ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 40 ETO STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.2.3 Formaldehyde sterilization
        6.2.1.2.3.1 Increasing efficacy of formaldehyde sterilization to drive market
TABLE 41 FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 42 FORMALDEHYDE STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.2.1.2.4 Other low-temperature sterilization products
TABLE 43 OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.1.3 Radiation sterilization
      6.2.1.3.1 Adoption in pharmaceutical and biopharmaceutical sectors to drive market
TABLE 44 RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 45 RADIATION STERILIZATION MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.1.4 Filtration sterilization equipment
      6.2.1.4.1 Growing adoption in pharmaceutical and food industries to drive expansion
TABLE 46 FILTRATION STERILIZERS OFFERED BY KEY MARKET PLAYERS
TABLE 47 FILTRATION STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.1.5 Other sterilization equipment
TABLE 48 OTHER STERILIZATION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.2.2 CONTRACT STERILIZATION SERVICES MARKET
TABLE 49 CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 50 CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 51 CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.2.1 EtO sterilization services
      6.2.2.1.1 Increasing demand for sterile medical devices to boost segment growth
TABLE 52 ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 53 ETO STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.2.2 Gamma sterilization services
      6.2.2.2.1 Increased efficiency and reliability to boost market growth
TABLE 54 GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 55 GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.2.3 E-beam sterilization services
      6.2.2.3.1 Fast processing time of E-beam sterilization to drive market
TABLE 56 E-BEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 57 E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.2.4 Steam sterilization services
      6.2.2.4.1 Reliable and versatile method across industries to drive market
TABLE 58 STEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 59 STEAM STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.2.2.5 Other contract sterilization services
TABLE 60 OTHER CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 61 OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
6.3 CONSUMABLES & ACCESSORIES
TABLE 62 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 63 CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.3.1 STERILIZATION INDICATORS
TABLE 64 STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS
TABLE 65 STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 66 STERILIZATION INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.3.1.1 Chemical indicators
      6.3.1.1.1 Cost effectiveness of chemical indicators to drive market
TABLE 67 CHEMICAL INDICATORS OFFERED BY KEY MARKET PLAYERS
TABLE 68 CHEMICAL INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.3.1.2 Biological indicators
      6.3.1.2.1 Effectiveness of biological indicators (BIs) to boost adoption
TABLE 69 BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS
TABLE 70 BIOLOGICAL INDICATORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.3.2 STERILIZATION POUCHES
TABLE 71 STERILIZATION POUCHES OFFERED BY KEY MARKET PLAYERS
TABLE 72 STERILIZATION POUCHES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.3.3 STERILIZATION LUBRICANTS
TABLE 73 STERILIZATION LUBRICANTS OFFERED BY KEY MARKET PLAYERS
TABLE 74 STERILIZATION LUBRICANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.3.4 STERILIZATION ACCESSORIES
TABLE 75 STERILIZATION ACCESSORIES OFFERED BY KEY MARKET PLAYERS
TABLE 76 STERILIZATION ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
6.4 CLEANING & DISINFECTION PRODUCTS
TABLE 77 CLEANING & DISINFECTION PRODUCTS OFFERED BY KEY MARKET PLAYERS
TABLE 78 CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 79 CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.4.1 DISINFECTANTS
TABLE 80 COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS
TABLE 81 DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.1.1 Disinfectants, by product type
TABLE 82 DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
      6.4.1.1.1 Hand disinfectants
        6.4.1.1.1.1 Rising awareness about health and hygiene to boost market growth
TABLE 83 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 84 HAND DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.1.2 Surface disinfectants
        6.4.1.1.2.1 Increasing prevalence of HAIs to drive use of surface disinfectants
TABLE 85 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 86 SURFACE DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.1.3 Skin disinfectants
        6.4.1.1.3.1 Rising prevalence of infectious diseases to drive growth of skin disinfectants market
TABLE 87 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 88 SKIN DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.1.4 Instrument disinfectants
        6.4.1.1.4.1 Growing number of surgeries to boost market growth
TABLE 89 INSTRUMENT DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 90 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.1.2 Disinfectants, by formulation
TABLE 91 DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION)
      6.4.1.2.1 Liquid disinfectants
        6.4.1.2.1.1 Increased adaptability to improve hygiene in specialty clinics, hospitals, and ambulatory surgery centers to drive growth
TABLE 92 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS
TABLE 93 LIQUID DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.2.2 Disinfectant wipes
        6.4.1.2.2.1 Versatility of disinfectant wipes to boost market growth
TABLE 94 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS
TABLE 95 DISINFECTANT WIPES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.2.3 Disinfectant sprays
        6.4.1.2.3.1 Increasing use of sprays for antimicrobial control to propel growth
TABLE 96 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS
TABLE 97 DISINFECTANT SPRAYS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.1.3 Disinfectants, by EPA classification
TABLE 98 DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION)
      6.4.1.3.1 Low-level disinfectants
        6.4.1.3.1.1 Low-level disinfectants to dominate market in future
TABLE 99 LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.3.2 Intermediate-level disinfectants
        6.4.1.3.2.1 Increasing utilization of intermediate-level disinfectants to fuel growth
TABLE 100 INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
      6.4.1.3.3 High-level disinfectants
        6.4.1.3.3.1 Effectiveness in disinfecting heat-sensitive, critical, and semi-critical items to drive demand
TABLE 101 HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.4.2 CLEANING & DISINFECTION EQUIPMENT
TABLE 102 CLEANING & DISINFECTION EQUIPMENTS OFFERED BY KEY MARKET PLAYERS
TABLE 103 CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 104 CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.2.1 Washer disinfectors
      6.4.2.1.1 Efficiency in cleaning and disinfecting medical devices and equipment to drive market
TABLE 105 WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS
TABLE 106 WASHER DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.2.2 Flusher disinfectors
      6.4.2.2.1 Rising demand to mitigate spread of HAIs to drive market growth
TABLE 107 FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS
TABLE 108 FLUSHER DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.2.3 UV-ray disinfectors
      6.4.2.3.1 Efficacy in addressing broad spectrum of microorganisms to drive market
TABLE 109 UV-RAY DISINFECTORS OFFERED BY KEY MARKET PLAYERS
TABLE 110 UV-RAY DISINFECTORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.2.4 Ultrasonic cleaners
      6.4.2.4.1 Improved efficacy in disinfecting medical instruments to boost demand
TABLE 111 ULTRASONIC CLEANERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.4.2.5 Other cleaning & disinfection equipment
TABLE 112 OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.4.3 LUBRICANTS & CLEANING SOLUTIONS
    6.4.3.1 Increasing significance of lubrication in reprocessing of medical devices to boost market
TABLE 113 LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 114 LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.4.4 DISINFECTION & CLEANING ACCESSORIES
    6.4.4.1 Stringent regulatory standards to drive demand
TABLE 115 DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
6.5 PROTECTIVE BARRIERS
TABLE 116 PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 117 PROTECTIVE BARRIERS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.5.1 MEDICAL NONWOVENS
TABLE 118 MEDICAL NONWOVENS OFFERED BY KEY MARKET PLAYERS
TABLE 119 MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 120 MEDICAL NONWOVENS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.5.1.1 Face masks
      6.5.1.1.1 Increasing prevalence of respiratory diseases to drive market growth
TABLE 121 FACE MASKS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.5.1.2 Surgical gowns
      6.5.1.2.1 Growing awareness about infection control to fuel growth
TABLE 122 LEVELS OF SURGICAL GOWNS
TABLE 123 SURGICAL GOWNS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.5.1.3 Surgical drapes
      6.5.1.3.1 Increasing adoption of surgical drapes to propel market growth
TABLE 124 SURGICAL DRAPES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.5.2 GLOVES
    6.5.2.1 Increasing concern about personnel safety to result in widespread adoption of gloves
TABLE 125 GLOVES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.5.3 COVERS & CLOSURES
    6.5.3.1 Creating safe environments in healthcare and food industries supports market growth
TABLE 126 COVERS & CLOSURES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.5.4 GOGGLES
    6.5.4.1 Growing use of protective gear in research laboratories and hospitals to positively impact market
TABLE 127 GOGGLES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
6.6 ENDOSCOPE REPROCESSING PRODUCTS
TABLE 128 ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS
TABLE 129 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 130 ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.6.1 ENDOSCOPE REPROCESSING CONSUMABLES
    6.6.1.1 Ensuring effectiveness and safety of endoscope reprocessing procedures to drive market growth
TABLE 131 ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS
TABLE 132 ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.6.2 ENDOSCOPE REPROCESSING EQUIPMENT
TABLE 133 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 134 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.6.2.1 Automated endoscope reprocessors
      6.6.2.1.1 Enhanced efficiency of AERs compared to manual cleaning to foster growth
TABLE 135 AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS
TABLE 136 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
    6.6.2.2 Endoscope tracking systems
    6.6.2.3 Rising concerns about HAIs to drive demand for efficient reprocessing and traceability
TABLE 137 ENDOSCOPE TRACKING SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 138 ENDOSCOPE TRACKING SYSTEMS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
  6.6.3 OTHER ENDOSCOPE REPROCESSING EQUIPMENT
TABLE 139 OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS
TABLE 140 OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)
6.7 OTHER INFECTION CONTROL PRODUCTS
TABLE 141 OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY/REGION, 2021–2029 (USD MILLION)

7 INFECTION CONTROL MARKET, BY END USER

7.1 INTRODUCTION
TABLE 142 INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION)
7.2 HOSPITALS & CLINICS
  7.2.1 STRINGENT REGULATIONS AND STANDARDS FOR HAIS PREVENTION TO DRIVE MARKET
TABLE 143 EXAMPLES OF CRITICAL-ACCESS HOSPITALS IMPLEMENTING EVIDENCE-BASED PROGRAMS FOR HAIS
TABLE 144 INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
7.3 MEDICAL DEVICE COMPANIES
  7.3.1 INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE GROWTH
TABLE 145 INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION)
7.4 PHARMACEUTICAL COMPANIES
  7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET
TABLE 146 DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES
TABLE 147 INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION)
7.5 LIFE SCIENCE INDUSTRY
  7.5.1 INCREASING PREVALENCE OF CLINICAL RESEARCH INITIATIVES TO PROMOTE GROWTH
TABLE 148 INFECTION CONTROL MARKET FOR LIFE SCIENCE INDUSTRY, BY COUNTRY, 2021–2029 (USD MILLION)
7.6 FOOD INDUSTRY
  7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO DRIVE GROWTH
TABLE 149 INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2029 (USD MILLION)
7.7 OTHER END USERS
TABLE 150 INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION)

8 INFECTION CONTROL MARKET, BY REGION

8.1 INTRODUCTION
FIGURE 38 INFECTION CONTROL MARKET IN CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 151 INFECTION CONTROL MARKET, BY REGION, 2021–2029 (USD MILLION)
8.2 NORTH AMERICA
  8.2.1 RECESSION IMPACT
FIGURE 39 NORTH AMERICA: INFECTION CONTROL MARKET SNAPSHOT
TABLE 152 NORTH AMERICA: INFECTION CONTROL MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION)
TABLE 154 NORTH AMERICA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 155 NORTH AMERICA: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 158 NORTH AMERICA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 159 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 160 NORTH AMERICA: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 161 NORTH AMERICA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 162 NORTH AMERICA: DISINFECTANTS MARKET, BY PRODUCT TYPE, 2021–2029 (USD MILLION)
TABLE 163 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION)
TABLE 165 NORTH AMERICA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 166 NORTH AMERICA: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 167 NORTH AMERICA: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 168 NORTH AMERICA: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 169 NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 170 NORTH AMERICA: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION)
  8.2.2 US
    8.2.2.1 Rising prevalence of healthcare-associated infections (HAIs) to drive market
TABLE 171 US: KEY MACRO INDICATORS
TABLE 172 US: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION)
TABLE 173 US: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 174 US: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 175 US: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 176 US: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 177 US: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 178 US: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 179 US: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 180 US: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 181 US: DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 182 US: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION)
TABLE 183 US: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION)
TABLE 184 US: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 185 US: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 186 US: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 187 US: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 188 US: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 189 US: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION)
  8.2.3 CANADA
    8.2.3.1 Rising geriatric population to support market growth
TABLE 190 CANADA: KEY MACRO INDICATORS
TABLE 191 CANADA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021–2029 (USD MILLION)
TABLE 192 CANADA: STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 193 CANADA: STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 194 CANADA: HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 195 CANADA: LOW-TEMPERATURE STERILIZATION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 196 CANADA: CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 197 CANADA: CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 198 CANADA: STERILIZATION INDICATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 199 CANADA: CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 200 CANADA: DISINFECTANTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 201 CANADA: DISINFECTANTS MARKET, BY FORMULATION, 2021–2029 (USD MILLION)
TABLE 202 CANADA: DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2021–2029 (USD MILLION)
TABLE 203 CANADA: CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 204 CANADA: PROTECTIVE BARRIERS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 205 CANADA: MEDICAL NONWOVENS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 206 CANADA: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 207 CANADA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION)
TABLE 208 CANADA: INFECTION CONTROL MARKET, BY END USER, 2021–2029 (USD MILLION)

The global infection control market will grow at a steady pace of around 6% from $10.5 billion in 2012 to $14.0 billion by 2017.

The rise in tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics has triggered the growth of medical sterilization and disinfection market. The increase in hospital acquired infections or nosocomial infections have forced the medical authorities to take stringent regulatory actions to curb these infections with the use of sterilized and disinfected medical devices.

The major players in Infection Control Market are

  • Getinge (Sweden)
  • Steris (U.S.)
  • Advanced Sterilization Product (U.S.)
  • Medivators (U.S.)
  • 3M (U.S.)
  • Cardinal Health (U.S.)

There has been a rise in trend for contract sterilization services due to stringent regulatory requirements from regulatory agencies like ISO and AMMI. The OEMs prefer outsourcing as it helps in cost reduction in sterilizing equipments in-house by focusing on their core competencies of business. However, in the near future in-house sterilization is expected to give healthy competition to contract sterilization service market mainly due to advent of hydrogen gas plasma and vapor hydrogen peroxide that are preferred to be used in-house. It also provides better quality assurance with just-in-time facility for sterilized products. Gamma and E-beam services are poised to have better growth over ETO in the near future due to their wider applications with respect to food, pharmaceutical, medical devices, life sciences and cosmetic products sterilization.

North America accounts for the largest share of the infection control market; however, Asia is expected to display favorable growth in the coming years, primarily due to rise in awareness, growth of ageing population, increase in number of surgeries, and growth in per capita income.



More Publications